SMARCB1 and atypical teratoid rhabdoid tumor: Although SMARCA4 mutations are less penetrant for atypical teratoid rhabdoid tumor than SMARCB1, SCCOHT was exclusively observed in patients constitutionally carrying the deleterious variant of SMARCA4 [12].